Quanterix Corporation Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
Quanterix Corporation (QTRX) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings of -$1.42 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings · last filed 2026-08-10
- Quanterix Corporation fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2026-06-30 was $79.00K.
- Quanterix Corporation fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2026-03-31 was -$1.50M, a 496.04% decline year-over-year.
- Quanterix Corporation fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-12-31 was -$595.00K.
- Quanterix Corporation fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-09-30 was -$58.00K.
- Quanterix Corporation fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2025 was -$4.55M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month |
|---|---|---|---|---|
| 2026-06-30 | $79.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$1.42M 10-Q · filed 2026-08-10 | -$2.02M derived: sum of 3 quarters · filed 2026-08-10 | -$2.08M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$1.50M 10-Q · filed 2026-05-06 | -$2.10M derived: sum of 2 quarters · filed 2026-05-06 | -$2.15M derived: sum of 3 quarters · filed 2026-05-06 | -$6.43M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$595.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$653.00K derived: sum of 2 quarters · filed 2026-03-02 | -$4.93M derived: sum of 3 quarters · filed 2026-08-10 | -$4.55M 10-K · filed 2026-03-02 |
| 2025-09-30 | -$58.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$4.33M derived: sum of 2 quarters · filed 2026-08-10 | -$3.95M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | -$4.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$3.89M 10-Q · filed 2026-08-10 | ||
| 2025-03-31 | $379.00K 10-Q · filed 2026-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |